BN vs. NOVO-B.CO
BN (Brookfield Corporation) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. BN operates in Asset Management (Financial Services), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, BN returned 15.61%/yr vs 17.63%/yr for NOVO-B.CO. At a 0.21 correlation, their price movements are largely independent.
Performance
BN vs. NOVO-B.CO - Performance Comparison
Loading charts...
Different Trading Currencies
BN is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BN achieves a -1.31% return, which is significantly higher than NOVO-B.CO's -10.15% return. Over the past 10 years, BN has underperformed NOVO-B.CO with an annualized return of 15.61%, while NOVO-B.CO has yielded a comparatively higher 17.63% annualized return.
BN
- 1D
- 0.40%
- 1M
- -4.88%
- YTD
- -1.31%
- 6M
- -0.68%
- 1Y
- 17.87%
- 3Y*
- 28.32%
- 5Y*
- 12.10%
- 10Y*
- 15.61%
NOVO-B.CO
- 1D
- 1.53%
- 1M
- -5.28%
- YTD
- -10.15%
- 6M
- -8.95%
- 1Y
- -41.84%
- 3Y*
- 6.83%
- 5Y*
- 19.41%
- 10Y*
- 17.63%
BN vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | -1.31% | 20.54% | 44.18% | 28.60% | -34.80% | 49.30% | 8.99% | 52.68% | -10.65% | 33.82% |
NOVO-B.CO Novo Nordisk A/S | -10.15% | -39.54% | -15.04% | 214.95% | 23.90% | 65.39% | 27.16% | 32.88% | -10.64% | 58.82% |
Correlation
The correlation between BN and NOVO-B.CO is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 2007 | 0.21 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BN vs. NOVO-B.CO — Risk / Return Rank
BN
NOVO-B.CO
BN vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Brookfield Corporation (BN) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BN | NOVO-B.CO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.30 | ||
| Sortino ratioReturn per unit of downside risk | +1.80 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 0.88 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.69 | -0.79 | +1.48 |
| Martin ratioReturn relative to average drawdown | 1.90 | -1.17 | +3.07 |
Loading charts...
Drawdowns
BN vs. NOVO-B.CO - Drawdown Comparison
The maximum BN drawdown since its inception was -82.22%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for BN and NOVO-B.CO.
Loading charts...
Drawdown Indicators
| BN | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.22% | -74.86% | -7.36% |
Max Drawdown (1Y)Largest decline over 1 year | -22.05% | -54.48% | +32.43% |
Max Drawdown (3Y)Largest decline over 3 years | -27.84% | -74.86% | +47.02% |
Max Drawdown (5Y)Largest decline over 5 years | -41.85% | -74.86% | +33.01% |
Max Drawdown (10Y)Largest decline over 10 years | -51.42% | -74.86% | +23.44% |
Current DrawdownCurrent decline from peak | -7.89% | -67.88% | +59.99% |
Average DrawdownAverage peak-to-trough decline | -28.51% | -12.38% | -16.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.99% | 36.72% | -28.73% |
Volatility
BN vs. NOVO-B.CO - Volatility Comparison
The current volatility for Brookfield Corporation (BN) is 10.05%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 12.08%. This indicates that BN experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BN | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.05% | 12.08% | -2.03% |
Volatility (6M)Calculated over the trailing 6-month period | 22.60% | 40.71% | -18.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.82% | 55.70% | -26.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.27% | 58.93% | -27.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.17% | 45.48% | -15.31% |
Dividends
BN vs. NOVO-B.CO - Dividend Comparison
BN's dividend yield for the trailing twelve months is around 0.55%, less than NOVO-B.CO's 4.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | 0.42% | 0.52% | 0.56% | 0.70% | 1.44% | 1.12% | 1.55% | 1.11% | 1.56% | 1.29% | 1.58% | 1.50% |
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
Financials
BN vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Brookfield Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BN and NOVO-B.CO have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for BN and NOVO-B.CO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer